Monoclonal B lymphocytosis (MBL) is defined as the presence of a clonal B-cell population in the peripheral blood with fewer than 5 × 109/L B-cells and no other signs of a lymphoproliferative disorder. The majority of cases of MBL have the immunophenotype of chronic lymphocytic leukemia (CLL).
Monoclonal B-cell lymphocytosis (MBL) is an asymptomatic hematologic condition defined by the presence of a small (<5 x 109/L) clonal B-cell population in the peripheral blood in the absence of lymph-node enlargement, cytopenias or autoimmune diseases.Feb 4, 2014
D72.820Lymphocytosis (symptomatic) D72. 820 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
B-cell lymphoproliferative disorders are conditions in the blood involving uncontrolled growth of lymphocytes (white blood cells). These conditions include such cancers as multiple myeloma, Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), and such precursor conditions as monoclonal B-cell lymphocytosis.
Monoclonal B-cell lymphocytosis (MBL) is a non-cancerous condition. This condition causes an increased number of abnormal B-cells called lymphocytes in the blood. Lymphocytes are a type of white blood cell and fight infection.
HC-MBL progressing to CLL. Monoclonal B cell populations can be detected long before CLL diagnosis, even up to 6.4 years (13). However, the majority of 'CLL-like' HC-MBL cases remain stable overtime; progression to CLL has been estimated at a rate of 1-4% per year (1).Nov 11, 2021
288.60288.60 - Leukocytosis, unspecified | ICD-10-CM.
ICD-10 | Elevated white blood cell count, unspecified (D72. 829)
Lymphocytosis (lim-foe-sie-TOE-sis), or a high lymphocyte count, is an increase in white blood cells called lymphocytes. Lymphocytes help fight off diseases, so it's normal to see a temporary increase after an infection.
Monoclonal B-cell lymphocytosis (MBL) is a premalignant condition characterized by the presence of less than 5000/μL circulating clonal B cells in otherwise healthy individuals. Three subcategories have been identified according to the immunophenotypic features: CLL-like, CD5(+) atypical, and CD5(−) MBL.
Monoclonal B-cell lymphocytosisSymptomsNoneComplicationsMay progress to chronic lymphocytic leukemia or certain lymphoma types; increased risk of developing non-hematologic cancers, serious infections, and kidney diseaseDurationchronicTypesCLL/SLL, atypical CLL/SLL, non-CLL/SLL, and MBL-MZ2 more rows
Lymphocytes are a type of white blood cell. They play an important role in your immune system, helping your body fight off infection. Many underlying medical conditions can cause lymphocytosis. High lymphocyte blood levels indicate your body is dealing with an infection or other inflammatory condition.Mar 29, 2018
Monoclonal B-cell lymph ocytosis ( MBL) is defined by a monoclonal B-cell count < 5 x 10 to the ninth/L in the peripheral blood in subjects who have no associated lymphadenopathy, organ omegaly, other extramedullary involvement, or any other feature of a B-cell lymphoproliferative disorder.
International Classification of Diseases for Oncology, Third Edition, Second Revision. Geneva: World Health Organization, 2020
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism ( D50–D89) Other disorders of blood and blood-forming organs ( D70-D77) Other disorders of white blood cells ( D72)
Types of blood disorders include. Platelet disorders, excessive clotting, and bleeding problems, which affect how your blood clots.
The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets. Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. They can be acute or chronic.
Monoclonal B-cell lymph ocytosis ( MBL) is defined by a monoclonal B-cell count < 5 x 10 to the ninth/L in the peripheral blood in subjects who have no associated lymphadenopathy, organ omegaly, other extramedullary involvement, or any other feature of a B-cell lymphoproliferative disorder.
International Classification of Diseases for Oncology, Third Edition, Second Revision. Geneva: World Health Organization, 2020
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A plasma cell disorder in which an abnormal amount of a single immunoglobulin is present in the serum. Up to 25% of cases of monoclonal gammopathy of undetermined significance (mgus) progress to a b-cell malignancy or myeloma.
Functional activity. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology]